image

Successful Local Anesthesia for Restorative Dentistry and Endodontics, Second Edition

Successful
Local Anesthesia

FOR RESTORATIVE DENTISTRY AND ENDODONTICS

Second Edition

Al Reader, DDS, MS

Emeritus Professor and Past Director of the

Advanced Endodontic Program

College of Dentistry

The Ohio State University

Columbus, Ohio

John Nusstein, DDS, MS

Professor and Chair of the Division of Endodontics

College of Dentistry

The Ohio State University

Columbus, Ohio

Melissa Drum, DDS, MS

Associate Professor and Director of the

Advanced Endodontic Program

College of Dentistry

The Ohio State University

Columbus, Ohio

images

Dedication

This book is dedicated to the current and former endodontic graduate students who shared our goal of profound pulpal anesthesia.

Library of Congress Cataloging-in-Publication Data

Names: Reader, Al, author. | Nusstein, John, author. | Drum, Melissa, author.

Title: Successful local anesthesia for restorative dentistry and endodontics

   / Alfred Reader, John Nusstein, Melissa Drum.

Description: Second edition. | Hanover Park, IL : Quintessence Publishing Co

   Inc, [2017] | Includes bibliographical references and index.

Identifiers: LCCN 2016045951 (print) | LCCN 2016046585 (ebook) | ISBN

   9780867157437 (softcover) | eISBN 9780867158977

Subjects: | MESH: Anesthesia, Dental | Anesthesia, Local--methods | Dental

   Restoration, Permanent | Root Canal Therapy

Classification: LCC RK510 (print) | LCC RK510 (ebook) | NLM WO 460 | DDC 617.9/676--dc23

LC record available at https://lccn.loc.gov/2016045951

image

©2017 Quintessence Publishing Co, Inc

Quintessence Publishing Co Inc

4350 Chandler Drive

Hanover Park, IL 60133

www.quintpub.com

5 4 3 2 1

All rights reserved. This book or any part thereof may not be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, or otherwise, without prior written permission of the publisher.

Editor: Leah Huffman

Design: Erica Neumann

Production: Angelina Schmelter

Contents

 ■     Preface

 ■     Acknowledgments

1Clinical Factors Related to Local Anesthesia
2Mandibular Anesthesia
3Maxillary Anesthesia
4Supplemental Anesthesia
5Clinical Tips for Management of Routine Restorative Procedures
6Endodontic Anesthesia
7Clinical Tips for Management of Specific Endodontic Situations

Preface

Why do patients avoid going to the dentist? According to a survey by the American Dental Association,1 fear of pain is the greatest factor that prevents patients from visiting their dentist. Additional surveys2,3 have found that 90% of dentists have some anesthetic difficulties during restorative dentistry procedures. Because adequate pulpal anesthesia is a clinical problem, we and other authors have performed a number of research studies on local anesthesia over the last 30 years. We are excited to present some of these findings in this book.

From the Latin word patiens, the word patient in English originally meant “one who suffers.” Unfortunately, some patients may still “suffer” when visiting the dentist. Our goal is to reduce pain and manage it successfully. That being said, profound pulpal anesthesia is a cornerstone to the delivery of dental care. Administration of local anesthesia is one of the most common procedures in clinical practice. It is invariably the first procedure we perform, and it affects almost everything we do during that appointment. If the patient is not adequately anesthetized and you have some extensive restorative work planned, difficulties arise. The information in this book explains why problems occur and offers clinical solutions to help clinicians stay on schedule.

Fortunately, local anesthesia has evolved tremendously over the last 25 years just as the materials and techniques have evolved in restorative dentistry and endodontics. The current technology and drug formulations used for local anesthesia have made it so much easier to treat patients successfully. We now have the ability to anesthetize patients initially, provide anesthesia for the full appointment, and reverse some of the effects of soft tissue anesthesia if desired. Priceless!

This book covers the research-based rationale, advantages, and limitations of the various anesthetic agents and routes of administration. A special emphasis is placed on supplemental anesthetic techniques that are vital to the practice of dentistry. However, this book does not cover the basic techniques utilized for the delivery of local anesthetics because that information is readily available elsewhere in textbooks and other publications.

In addition, this book emphasizes information for the restorative dentist and endodontist because the requirements for pulpal anesthesia are different than those for oral surgery, implant dentistry, periodontics, and pediatric dentistry. Eighty-five percent of local anesthesia teaching in dental school is done by oral and maxillofacial surgery departments,4 and while they do an excellent job, it is sometimes difficult for oral surgeons to appreciate the requirements for pulpal anesthesia in restorative dentistry and endodontic therapy. Furthermore, we should value our experience. Whereas education is what you get during your training, experience is what you get afterward. A young practitioner knows the rules, but an older practitioner knows the exceptions. Experience is a wonderful thing that enables us to recognize a mistake when we make it.

Throughout the book, the information has been divided into specific topics so it is understandable and easy to reference. When indicated, summary information has been provided. References to published literature are included in the chapters because clinicians within the specialty of endodontics (of which we are members) communicate with each other by quoting authors and studies. We also think it is important to credit the authors for their contributions to the literature on local anesthesia.

This book is a clinical adjunct to help you successfully anesthetize patients using the newest technology and drugs available. Indeed, the information presented here will help you to provide painless treatment. Pulpal anesthesia is emphasized throughout this book. That is, pulpal anesthesia is required by the restorative dentist and endodontist in order to perform painless treatment. We think that is a worthy goal for the dental profession. However, as Will Rogers once said, to be successful, you must know what you are doing, like what you are doing, and believe in what you are doing.

References

1. ADA survey. Influences on dental visits. ADA News 1998;11(2):4.

2. Kaufman E, Weinstein P, Milgrom P. Difficulties in achieving local anesthesia. J Am Dent Assoc 1984;108:205–208.

3. Weinstein P, Milgrom P, Kaufman E, Fiset L, Ramsay D. Patient perceptions of failure to achieve optimal local anesthesia. Gen Dent 1985;33:218–220.

4. Dower JS. A survey of local anesthesia course directors. Anesth Prog 1998;45:91–95.

Acknowledgments

We want to acknowledge the time spent away from our spouses (Dixie Reader, Tammie Nusstein, and Jason Drum) in completing this work. We are so grateful they were willing to help us produce a thoughtful addition to local anesthesia.

As the senior author, Al Reader would like to thank his coauthors for all their help: “My associates and I always compromise. I admit I’m wrong and they agree with me.”

All royalties from the sale of this book will be equally divided between the American Association of Endodontists’ Foundation and The Ohio State University Endodontic Graduate Student Research Fund to support further research on anesthesia and pain control.

1 Clinical Factors Related to Local Anesthesia

After reading this chapter, the practitioner should be able to:

Discuss the clinical factors related to local anesthesia.

Provide ways of confirming clinical anesthesia.

Describe issues related to local anesthesia.

Explain the effects anxiety has on local anesthesia.

Discuss the use of vasoconstrictors.

Characterize injection pain.

Evaluate the use of topical anesthetics.

Discuss alternative modes of reducing pain during injections.

Clinical pulpal anesthesia is dependent on the interaction of three major factors: (1) the dentist, (2) the patient, and (3) local anesthesia (Fig 1-1). The dentist is dependent on the local anesthesia agents as well as his or her technique. In addition, the dentist is dependent on the interaction with the patient (rapport/confidence). How the patient interacts with the administration of local anesthesia is determined by a number of clinical factors.

images

Fig 1-1 The relationship of pulpal anesthesia to the patient, dentist, and local anesthesia.

Confirming Pulpal Anesthesia in Nonpainful Vital Teeth

Lip numbness

A traditional method to confirm anesthesia usually involves questioning patients by asking if their lip is numb (Fig 1-2). Although lip numbness can be obtained 100% of the time, pulpal anesthesia may fail in the mandibular first molar in 23% of patients.1–16 Therefore, lip numbness does not always indicate pulpal anesthesia. However, lack of lip numbness for an inferior alveolar nerve block (IANB) does indicate that the injection was “missed,” and pulpal anesthesia will not be present.

images

Fig 1-2 Lip numbness does not guarantee pulpal anesthesia.

IN CONCLUSION, lip numbness does not always indicate pulpal anesthesia.

Soft tissue testing

Using a sharp explorer to “stick” the soft tissue (gingiva, mucosa, lip, tongue) in the area of nerve distribution (Fig 1-3) has a 90% to 100% incidence of success.2–5 Regardless, pulpal anesthesia may still not be present for the mandibular first molar in 23% of patients.1–16 Negative mucosal sticks usually indicate that the mucosal tissue is anesthetized.

images

Fig 1-3 A lack of patient response to mucosal or gingival “sticks” is a poor indicator of pulpal anesthesia.

IN CONCLUSION, the lack of patient response to sharp explorer sticks is a poor indicator of pulpal anesthesia.

Commencing with treatment

The problem with commencing treatment without confirming anesthesia is that there is no way to know if the patient is numb until we start to drill on the tooth. This may create anxiety for both the patient and the dentist. A typical scenario involving a crown preparation on a mandibular molar can become problematic if the patient feels pain when the mesiobuccal dentin is reached with the bur. If the patient reacts to the pain, the dentist may say, “Oh, did you feel that?” and then may try to continue with treatment. If the patient reacts again when the mesiobuccal dentin is touched with the bur, the dentist may try to work around the pain the patient is feeling by saying, “I’ll be done in a minute.” Such a situation would not make a good day for the dentist or the patient.

IN CONCLUSION, commencing with treatment without confirming anesthesia may add apprehension for the dentist and patient because neither one knows if the tooth is anesthetized.

Cold refrigerant or electric pulp testing

A more objective measurement of anesthesia in nonpainful vital teeth is obtained with an application of a cold refrigerant of 1,1,1,2-tetrafluoroethane or by using an electric pulp tester (EPT). Cold refrigerant or the EPT can be used to test the tooth under treatment for pulpal anesthesia prior to beginning a clinical procedure.17–20 A dental assistant could test the tooth to determine when pulpal anesthesia is obtained and then inform the dentist that treatment can be started.

In a very anxious patient, the use of pulp testing may cause a very painful reaction. Apprehensive patients can become sufficiently keyed up to react to even minimal stimulation. They may say, “Of course I jumped, it hurts!” or “It’s only normal to jump when you know it is going to hurt.”

IN CONCLUSION, pulp testing with a cold refrigerant or an EPT will indicate if the patient has pulpal anesthesia. For anxious patients, pulp testing may need to be postponed until the patient can be conditioned to accept noninvasive diagnostic procedures.

Cold testing

A cold refrigerant tetrafluoroethylene (Hygenic Endo-Ice, Coltène/Whaledent) (Fig 1-4) can be used to test for pulpal anesthesia before commencing drilling on the tooth. The technique for cold testing is quick and easy; it takes only seconds to complete and does not require special equipment. Once the patient is experiencing profound lip numbness, the cold refrigerant is sprayed on a large cotton pellet held with cotton tweezers21 (Fig 1-5). The cold pellet is then placed on the tooth (Fig 1-6). If clinical anesthesia has been successful, applications of cold refrigerant should not be felt. If the patient feels pain with application of the cold, supplemental injections should be given. If no pain is felt with the cold, it is likely that pulpal anesthesia has been obtained. Testing with a cold refrigerant is more convenient than with an EPT and gives a good indication of clinical anesthesia.

images

Fig 1-4 A cold refrigerant may be used to test for pulpal anesthesia before the start of a clinical procedure. (Courtesy of Coltène/Whaledent.)

images

Fig 1-5 The cold refrigerant is sprayed on a large cotton pellet.

images

Fig 1-6 The pellet with the cold refrigerant is applied to the surface of the tooth.

Pulp testing with a cold refrigerant can be performed effectively on gold crowns and porcelain-fused-to-metal crowns. In fact, pulp testing is fairly easy to use in these situations because the metal conducts the cold very nicely. Miller and coauthors21 also showed that pulp testing with a cold refrigerant is effective for all-ceramic crowns.

IN CONCLUSION, pulp testing with a cold refrigerant is a reliable way to confirm clinical pulpal anesthesia, even in teeth with gold, porcelain-fused-to-metal, and all-ceramic crowns.

Electric pulp testing

In order to use the EPT (Kerr Vitality Scanner, SybronEndo) (Fig 1-7), the tooth should be dried with a gauze pad or cotton roll. Toothpaste is applied to the probe tip of the pulp tester before placing the tip on the middle of the labial surface (for anterior teeth) or buccal surface (for posterior teeth) of the tooth to be anesthetized (Fig 1-8). The Kerr EPT automatically starts on contact with the tooth and continues to apply current until the maximum output of a reading of 80 is reached. On removal from the tooth, the EPT automatically resets to 0. Contemporary EPTs are easy to use and no longer rely on the dentist to increase the current rate manually via a dial or to reset the unit manually.

images

Fig 1-7 An EPT may also be used to test for pulpal anesthesia before a clinical procedure is started. (Courtesy of SybronEndo.)

images

Fig 1-8 The EPT probe is placed on the surface of the tooth.

Kitamura and coauthors22 reported that the EPT was 99% accurate when testing teeth determined to be vital. Dreven and colleagues17 and Certosimo and Archer18 showed that a lack of patient response to an 80 reading with the EPT was an assurance of pulpal anesthesia in nonpainful vital teeth.

Certosimo and Archer18 demonstrated that patients who responded to EPT readings of less than 80 experienced pain during operative procedures in normal teeth. Therefore, using the EPT prior to beginning dental procedures on nonpainful vital teeth will provide the clinician with a reliable indicator of pulpal anesthesia. We have used the EPT experimentally in many of the studies outlined in this book because it is easier to use for constant pulp testing over a period of 60 minutes.

IN CONCLUSION, the EPT is very reliable in determining pulpal anesthesia in nonpainful vital teeth. Patient response to EPT readings less than the maximum output reading (80) indicate a lack of pulpal anesthesia.

EPT and cold testing in clinical practice

Almost all of the studies outlined in this book can be duplicated in your office. That is, by pulp testing teeth after giving different local anesthetic formulations and techniques, you can perform the same tests in your office to evaluate pulpal anesthesia. Wow!

Some may say that a negative response to pulp testing is not needed to perform restorative dentistry. This is true if you don’t mind the patient often experiencing pain during treatment.18 However, our goal is to have the patient experience no pulpal pain. While patients may tolerate being hurt during dental procedures, we think this is unnecessary in today’s modern dental practice.

IN CONCLUSION, pulp testing is a very valuable tool to determine pulpal anesthesia in clinical practice.

Clinical Local Anesthesia–Related Issues

Patient considerations

Pain versus pressure during treatment

The senior author remembers that when extracting painful teeth, I used to explain to patients that they were only feeling pressure during treatment—not pain. The explanation was that, although the local anesthetic was very effective at inhibiting the nerve fibers that transmit pain sensations, it did not have much of an effect on the nerves that transmit pressure sensations. While this theory may have some merit, it has never been proven, and the reason patients feel pain during treatment is much more complicated (see chapters 2 and 4). For example, voltage-gated sodium channels (VGSCs) exist on nerve membranes and differ in their roles in mediating peripheral pain.23–25 They are divided into channels that are blocked by the toxin tetrodotoxin (TTX) and the channels that are resistant to the toxin (TTX-R).26 A number of TTX-R channels are found on pain receptors NaV 1.8 and NaV 1.9,26 and these channels are somewhat resistant to local anesthetics.27

IN CONCLUSION, pressure transmission is an incomplete explanation of why patients react to dental treatment, and TTX-R channels are involved in resistance to local anesthetic action on nerves.

Patient reaction to local anesthetic injection

Brand and coauthors28 found that feeling tense (42%), clenching fists (14%), and moaning (13%) were the most common reactions to an IANB. Vika and coauthors29 reported that about 17% of patients indicated high fear to an injection during their last dental appointment, which may lead to avoidance of necessary treatment in the future.

IN CONCLUSION, some patients react negatively to receiving an IANB.

Patients who report previous difficulty with local anesthesia

In addition, patients who report having had difficulty with local anesthesia in the past are more likely to experience unsuccessful anesthesia.30 These patients will generally identify themselves with comments such as, “Novocaine doesn’t work on me” or “a lot of shots are needed to get my teeth numb.” A good clinical practice is to ask the patient if he or she has had previous difficulty achieving clinical anesthesia. If so, supplemental injections should be considered.

IN CONCLUSION, patients who report previous difficulty with anesthesia are more likely to experience unsuccessful anesthesia.

Dentist considerations

Dentist reaction to injections of local anesthetic

Simon and coauthors31 found that 19% of dentists reported that the administration of local anesthetic injections caused enough distress that they had at some point reconsidered dentistry as a career. And 6% considered it a serious problem. This study indicates that the administration of local anesthetic injections might contribute to overall professional stress for some dentists.

Anxious patients may not be the only ones anxious about local anesthetic injections. Dower and coauthors32 found that two-thirds of dentists described anxious patients as the main source of their anxiety, and 16% identified children as the main source of anxiety.

IN CONCLUSION, some dentists are stressed by giving a local anesthetic injection, and anxious patients and children can be sources of anxiety for the dentist.

Compassion fatigue

Moreover, a type of emotional burnout called compassion fatigue may affect many health care workers.33,34 Although we become doctors because we want to help people, controlling pain on a daily basis and performing treatment at a very high level of precision may take its toll. In fact, if patients feel pain during restorative treatment, we sometimes internalize the feeling as failure.

As dentists and professionals, we provide an extraordinary service to our patients. Our ability to provide exceptional treatment with a caring attitude is a most rewarding art. However, we also have the ability to not accept failure because we have the means to prevent it. Dentists have been maligned for many years because of pain. Unfortunately, some of the information that we have today that allows us to prevent patient pain was not available in the past. This is particularly true with the IANB; this injection fails often enough to present meaningful clinical problems. This book will outline the steps you need to take to overcome failure with this block.

IN CONCLUSION, we should not accept clinical failure of pulpal anesthesia when we have the means to prevent it from happening.

Anesthetic agents and dosages

Table 1-1 outlines the local anesthetic formulations available in the United States. The American Dental Association has specified a uniform color code to prevent confusion among brands. The maximum allowable dosage applies to complex oral and maxillofacial surgery procedures. The typical maximum dosage is for adults (weighing 150 pounds) who are undergoing typical restorative and endodontic procedures. Local anesthetic agents, common names, and milligrams per cartridge are presented in Table 1-2.

Table 1-1 Local anesthetics available in the United Statesa
Anesthetic Vasoconstrictor Dental cartridge color codeb MADc TMDc
2% lidocaine 1:100,000 epinephrine Red 13 8
2% lidocaine 1:50,000 epinephrine Green 13 8
2% lidocaine plain No vasoconstrictor Light blue 8 8
2% mepivacaine 1:20,000 levonordefrin Brown 11 8
3% mepivacaine plain No vasoconstrictor Tan 7
4% prilocaine 1:200,000 epinephrine Yellow
4% prilocaine plain No vasoconstrictor Black
0.5% bupivacaine 1:200,000 epinephrine Blue 10 10
4% articaine 1:100,000 epinephrine Gold 7 7
4% articaine 1:200,000 epinephrine Silver 7 7

aThe dosages were adapted from Malamed.35

bUniform dental cartridge color codes.

cThis table provides the maximum dosage in two formats. The maximum allowable dose (MAD) generally is approached only with complex oral and maxillofacial surgical procedures. The typical maximum dose (TMD) is the usual upper limit of drug dosage for most restorative and endodontic dental procedures. Both columns show the number of cartridges that would be required for an adult weighing 150 pounds (67.5 kg).

Table 1-2 Local anesthetics, common names, and milligrams per cartridge
Local anesthetic agent Common name(s) Cartridge (mg)
2% lidocaine with 1:100,000 epinephrine Xylocaine (Dentsply)
Lidocaine
36
2% lidocaine with 1:50,000 epinephrine Xylocaine
Lidocaine
36
2% mepivacaine with 1:20,000 levonordefrin Carbocaine (Cook-Waite)
Polocaine (Dentsply)
36
3% mepivacaine plain (no vasoconstrictor) Carbocaine Polocaine 54
4% prilocaine with 1:200,000 epinephrine Citanest Forte (Dentsply) 72
4% prilocaine plain (no vasoconstrictor) Citanest Plain (Dentsply) 72
0.5% bupivacaine with 1:200,000 epinephrine Marcaine (Cook-Waite)   9
4% articaine with 1:100,000 epinephrine Septocaine (Septodont)
Zorcaine (Cook-Waite)
Articadent (Dentsply)
72
4% articaine with 1:200,000 epinephrine Septocaine 72

Gray rubber stoppers

Most of the rubber stoppers of cartridges are colored gray (Fig 1-9). These rubber stoppers are not color coded and are not indicative of the drug the cartridge contains.

images

Fig 1-9 Gray anesthetic cartridge stoppers.

Orabloc articaine formulation

Orabloc (Patterson Dental) is an articaine local anesthetic containing a vasoconstrictor and is available in two epinephrine formulations—1:200,000 and 1:100,000. Supposedly, it is a “purer” form of articaine that has a 24-month shelf life at room temperature and very low manufacture-related degradation products, including articaine acid and epinephrine sulfonic acid, and it is sodium edetate free, methylparaben free, and latex free. As far as we are aware, no research has been performed on Orabloc in comparison with other commercially available products.

IN CONCLUSION, the articaine formulation of Orabloc needs to be evaluated for clinical efficacy.

Media hype: “Local anesthetics cause tooth cell death”

Zhuang and coauthors,36 using pig teeth and young permanent tooth pulp cells, found that prolonged exposure to high doses of local anesthetics interfered with the mitochondria of tooth cells and led to cell death. The researchers noted that further clinical studies are required before there is enough data to change clinical guidelines. They also urged parents not to be alarmed or withdraw their children from treatment if they need it.

IN CONCLUSION, exposing pig teeth and pulp cells to high doses of local anesthetics does not prove a correlation with clinical outcomes.

Cartridge volume—1.7 mL versus 1.8 mL

Robertson and coauthors37 measured the amount of anesthetic solution delivered with an aspirating syringe, a standard syringe with a 27-gauge needle, and the contents of 50 articaine cartridges and 50 lidocaine cartridges into a graduated syringe with 0.01 milliliter–increment divisions. Even though the articaine cartridge was marked externally as containing 1.7 mL (Fig 1-10), on average the anesthetic solution expressed was 1.76 mL. For the lidocaine cartridge, the amount was marked as 1.8 mL (Fig 1-11), but on average the anesthetic solution expressed was 1.76 mL. In general, a small amount of anesthetic solution remained in both cartridges after delivery of the solution with an aspirating syringe. The amount of anesthetic solution expressed was basically the same for both articaine and lidocaine. Some manufacturers are now labeling cartridges as 1.7 mL even though the anesthetic solution expressed is 1.76 mL.

images

Fig 1-10 Articaine cartridge showing 1.7 mL of anesthetic solution.

images

Fig 1-11 Lidocaine cartridge showing 1.8 mL of anesthetic solution.

IN CONCLUSION, cartridges marked 1.7 mL and 1.8 mL express the same amount of anesthetic solution.

Classification of local anesthetics and clinical implications

Generally, local anesthetic agents are classified as short, intermediate, or long-acting based on their pKa, lipid solubility, and protein binding.35 Short-duration drugs include 3% mepivacaine and 4% prilocaine. A long-acting drug is 0.5% bupivacaine with 1:200,000 epinephrine. Lidocaine, articaine, mepivacaine, and prilocaine, all with vasoconstrictors, are considered intermediate in action. However, Pateromichelakis and Prokopiou38 found that studies on isolated nerves can be poor guides to the clinical comparisons of local anesthetics. For example, clinical studies indicate that the duration of these drugs is different when used in nerve blocks versus infiltration or intraosseous injections. A good example is anesthetic agents like bupivacaine and etidocaine. While classified as long-acting agents, this duration only holds true for nerve blocks—not for maxillary infiltration, intraligamentary, or intraosseous anesthesia.11,39–41 Short-duration drugs like 3% mepivacaine and 4% prilocaine are effective for IANBs of at least 50 minutes4 but have a short duration for infiltration anesthesia in the maxilla.42,43

IN CONCLUSION, the overall classification of local anesthetics does not always correlate with clinical effectiveness.

Factors influencing local anesthetic effectiveness

Genetics

Some patients may not respond adequately to local anesthetic administration. Various studies44–47 have related pain or ineffectiveness of local anesthetic to genetic factors. Perhaps, one day in the future, we may be able to use genomic testing to improve the efficacy of local anesthetics by selecting drugs that offer the most appropriate pharmacologic usefulness. However, the problem with the gene pool is that there is no lifeguard.

IN CONCLUSION, genetics may play a role in anesthetic failure.

Red hair phenotype

Natural red hair color results from distinct mutations of the melanocortin-1 receptor (MC1R), which may modulate pain pathways.48–50 Red hair color is the phenotype for MC1R gene, which is associated with red hair, fair skin, and freckles in humans (Fig 1-12). Women with red hair have been reported to be more sensitive to some types of pain and may be resistant to subcutaneous lidocaine.48 Liem and coauthors49 reported that the anesthetic requirement for desflurane was increased in redheads. In a follow-up study, Binkley and coauthors50 found that genetic variations associated with red hair color were also associated with fear of dental pain and anxiety. However, Myles and coauthors51 found no evidence that patient hair color affects requirements or recovery characteristics in a broad range of surgical procedures.

images

Fig 1-12 Will this woman with red hair be more difficult to anesthetize?

Droll and coauthors52 investigated a possible link between certain variant alleles of the MC1R or its phenotypic expression (red hair) and anesthetic efficacy of the IANB in women. They found that neither red hair nor MC1R was significantly linked to success rates of the IANB in women with healthy pulps (Fig 1-13). Importantly, women with red hair and women with two red hair color alleles reported significantly higher levels of dental anxiety compared with women with dark hair or women with no red hair color alleles. Women with red hair also reported greater pain on needle insertion during the injection. It may be that the clinical impression of failed anesthesia in red-haired individuals is owed to the higher anxiety levels perceived in this population. During dental treatment, this population may be more likely to report nonpainful sensations (pressure, vibration, etc) as painful.

images

Fig 1-13 Incidence of pulpal anesthesia following an IANB for the central incisor (a), lateral incisor (b), first premolar (c), second premolar (d), first molar (e), and second molar (f) as determined by lack of response to an EPT at maximum reading (percentage of 80 readings), at each postinjection time interval, for red-haired and dark-haired women. There were no significant differences in anesthetic success for any of the teeth. Red hair was significantly linked to higher levels of dental anxiety but was unrelated to success rates of the IANB in women with healthy pulps. (Reprinted from Droll et al52 with permission.)

IN CONCLUSION, red-haired women do not have more failure with the IANB. However, red-haired women report significantly higher dental anxiety.

Gender differences

Authors have found that women try to avoid pain more than men, accept it less, and fear it more.53–55 Morin and coauthors56 found that women find postsurgical pain more intense than men, but men are more disturbed than women by low levels of pain that last several days. Anxiety may also modulate differences in pain response between men and women.54 Thus, we should be aware that women might react differently to pain than men. Tofoli and coauthors57 found that injection discomfort and effectiveness of local anesthetics were not related to phases of the menstrual cycle or use of oral contraceptives. However, Loyd and coauthors58 reported that a sexually dimorphic peripheral mechanism may modulate trigeminal pain processing and may be related to the luteal phase of the menstrual cycle.

IN CONCLUSION, women try to avoid pain more than men, accept it less, and fear it more.

Catastrophizing

Some patients may have an exaggerated negative mental set that occurs during an actual or anticipated painful experience.59 This is called catastrophizing. That is, these patients are already predisposed to have a painful experience during dental treatment.

IN CONCLUSION, clinicians may need to probe patients’ pain experiences and help them reappraise threats.

Pathways of dental fear

Five pathways related to dental fear have been recognized60: (1) The conditioning pathway occurs as a result of direct traumatic experiences. (2) The parental pathway relates to dental fear learned from parents or guardians. (3) The informative pathway is related to fearful experiences learned or heard about from others. (4) The verbal threat pathway comes from parents using the dental environment as punishment for bad behavior in children. (5) The visual vicarious pathway is caused by fear-inducing dental situations seen in the media. A recent study60 found that less fear was shown in older patients, men were more likely to cancel dental appointments because of fear, and different ethnic backgrounds adopt different pathways of fear.

IN CONCLUSION, there are different pathways of dental fear, and each has an influence on fear of dentistry.

Pregnancy and breastfeeding

For pregnant patients, elective treatment should be deferred, particularly in the first trimester. However, if treatment involving a painful procedure is required, many of the commonly available local anesthetic agents are safe to use.61 The United States Food and Drug Administration classifies articaine, mepivacaine, and bupivacaine as category C drugs.35 A category C classification means that “Either animal-reproduction studies have revealed adverse effects and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the fetus.”35,61 Lidocaine and prilocaine are classified as category B drugs. A category B classification means that “Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect that was not confirmed in controlled studies in women in the first trimester (and there is no evidence of a risk in later trimesters).”35

The manufacturer drug monographs that accompany local anesthetic agents place warning statements that these agents should not be used during pregnancy. These statements are placed for medicolegal reasons because the anesthetics have not been tested during pregnancy. To put things in perspective, congenital anomalies occur in 3% of the general population, yet the causes can be determined in less than 50% of these cases.61 Hagai and coauthors62 evaluated the rate of major anomalies after exposure to local anesthetics as part of dental care during pregnancy. They found that the use of local anesthetics, as well as dental treatment during pregnancy, did not present a major risk for anomalies.

In patients who are lactating, drugs do pass into the breast milk in very small quantities.63 If there is concern, the patient may be comforted by electing to use a breast pump, discarding the milk, and then providing the infant with formula or previously expressed milk for a day. If the practitioner is unsure about the safety of a drug, he or she could consult the National Institutes of Health LactMed database. This resource provides information on drug transference to breast milk, drug safety, and safe alternative drugs.

The most important aspect of care in the pregnant patient in pain is elimination of the source of pain by performing the indicated treatment. This approach will reduce the need for systemic medications.61

IN CONCLUSION, defer elective treatment for pregnant patients, particularly in the first trimester. However, if treatment involving a painful procedure is required for the pregnant or lactating patient, many of the commonly available local anesthetic agents are safe to use.

Elderly patients

Nordenram and Danielsson64 found that elderly patients had significantly shorter onset times of anesthesia when compared with younger patients. In general, older patients may also be more tolerant of pain than younger patients.65,66

IN CONCLUSION, older patients may tolerate pain better than younger patients.

Alcohol addiction

Patients with alcoholism have been found to be more sensitive to painful stimulation, and those with a history of depression/unhappiness may also have shallower pulpal anesthesia.67,68 In contrast, patients in recovery for alcohol addiction may not be at increased risk for inadequate pain control with local anesthesia.68

IN CONCLUSION, patients with alcoholism who are not in recovery may be more difficult to anesthetize.

Allergies and local anesthetics

Local anesthetics

Generally, amide local anesthetics have a very low chance of allergic reactions.69 Batinac and coauthors70 found that the most common symptoms related to administration of local anesthetics were cardiovascular reactions (18%). True allergic reactions were rare (less than 1%). In patients who have reported adverse reactions to local anesthetics, none had hypersensitivity reactions to the intradermal injection of local anesthetics.69 However, there have been case reports of hypersensitivity reactions to local anesthetics.69–78 Patients who have had anaphylactic reactions or serious idiosyncratic reactions to administration of local anesthetics should be referred to a dental anesthesiologist or oral surgeon for deep sedation or general anesthesia prior to restorative procedures.

IN CONCLUSION, patients who have had serious reactions to local anesthetics should be treated in conjunction with a dental anesthesiologist or oral surgeon.

Latex in dental cartridges

Shojaei and Haas76 performed a literature review on latex allergies. They concluded that the medical literature provides some evidence that latex allergen can be released into solutions by direct contact with natural latex stoppers within the cartridges. However, they stated that there are no cases of documented allergy for dental local anesthetics. Recently, some manufacturers have introduced latex-free dental cartridges for all of their product lines.

IN CONCLUSION, dental cartridges present little risk in latex allergy patients.

Sulfites

Sulfites are common additives to many food products and are present in small amounts in local anesthetic cartridges. The sulfites prevent the oxidation of the vasoconstrictor in dental formulations. Smolinske77 felt that anaphylactic or asthmatic reactions caused by parenteral administration of sulfite agents were different than reactions caused by foods. The reactions were rapid and had no predilection for steroid-dependent asthmatics. As stated by Naftalin and Yagiela,78 the best way to avoid a reaction in a patient with a true sulfite allergy would be to use a local anesthetic without a vasoconstrictor.

IN CONCLUSION, if a patient has a severe sulfite allergy, use an anesthetic solution without a vasoconstrictor.

Reversing soft tissue numbness

Patients may feel that residual soft tissue numbness interferes with their normal daily activities in three specific areas—perceptual (perception of altered physical appearance), sensory (lack of sensation), and functional (diminished ability to speak, smile, drink, and control drooling). Patients may complain that they are unable to eat a meal or talk normally after their dental visit. Patients often do not want to have lip and tongue numbness for hours after the appointment. Phentolamine mesylate (0.4 mg in a 1.7-mL cartridge; OraVerse, Septodont) is an agent that shortens the duration of soft tissue anesthesia (Fig 1-14). The duration of soft tissue anesthesia is longer than pulpal anesthesia and is often associated with difficulty eating, drinking, and speaking.79–81 The greatest value of using OraVerse is in the majority of dental procedures in which postoperative pain is not of concern. Clinical trials have evaluated the use of phentolamine in patients undergoing routine nonsurgical operative or periodontal procedures or implant placement and in asymptomatic endodontic patients.79–87 These studies have shown that phentolamine statistically reduces the time of soft tissue numbness when compared with a sham injection. Saunders and coauthors86 found that patients who experienced OraVerse reported a reduced duration of numbness (92%) and an improved dental experience (84%), 83% of the patients would recommend OraVerse to others, and 79% would have OraVerse used in future dental visits.

images

Fig 1-14 OraVerse is a safe product to help reverse soft tissue anesthesia.

Fowler and coauthors85 studied the use of OraVerse for reversal of soft tissue anesthesia in asymptomatic endodontic patients. They found that patients experienced an 88-minute decrease in time to return to normal maxillary soft tissue sensation, and a 47-minute decrease in time to return to normal in mandibular lip sensation. Postoperative pain and complications were minimal. Many patients may benefit from the use of a reversal agent when they have speaking engagements or important meetings or perform in musical or theatrical events.

Elmore and coauthors88 found that phentolamine significantly reduced duration of both pulpal and soft tissue anesthesia when administered either at 30 or 60 minutes after an IANB (Fig 1-15). Therefore, because pulpal anesthesia is also reversed fairly rapidly, phentolamine should be administered at the end of the dental appointment.

images

Fig 1-15 Incidence of pulpal anesthesia for the central incisor (a), lateral incisor (b), first premolar (c), second premolar (d), first molar (e), and second molar (f) as determined by lack of response to an EPT at maximum reading (percentage of 80 readings), at each postinjection time interval, for phentolamine/sham and sham/phentolamine injections. The injection of phentolamine at 30 minutes reversed pulpal anesthesia fairly rapidly. Phentolamine would be beneficial for patients who would like to experience a faster return to normal soft tissue function and sensation after the administration of local anesthesia. However, pulpal anesthesia is also reversed fairly rapidly. (Reprinted from Elmore et al88 with permission.)

OraVerse is administered with a standard syringe using the same location and same technique (infiltration or nerve block) and in the same proportion (1 to 1) as was used initially for the local anesthetic injection.

IN CONCLUSION, OraVerse is a safe product and would be beneficial for patients who would like to experience a faster return to normal soft tissue function after the administration of local anesthesia.

Anxiety and Pain

Anxious patients may be harder to anesthetize. Although dental injections are an important aspect of treatment for patients, injections can induce anxiety or fear and may be a reason for patients to avoid dental treatment.89 Van Wijk and Hoogstraten90 found that anxious patients felt more pain than that reported by less anxious patients. Anxious patients also have a tendency to overestimate anticipated pain.91 Vika and coauthors92 reported that about 17% of patients indicated high fear during their last dental appointment.

Patients who are anxious have reduced pain tolerances.93 Therefore, anxious patients may be harder to anesthetize and may require supplemental techniques (articaine infiltration of mandibular teeth or intraosseous or intraligamentary injections).

In addition, dental anxiety is less prevalent among older adults (over 50 years of age) than in younger patients.94

Especially for dental students transitioning to the clinical years, one of the highest levels of anxiety was associated with hurting patients.95 When faced with specific clinical situations, students were stressed by failed local anesthesia.95

However, Corah and coauthors96 found that the dentist’s explicit dedication to prevent pain was the most important dentist behavior to the patient to reduce patient anxiety and increase satisfaction. Friendliness, working quickly, being calm, and giving moral support were important auxiliary behaviors.

IN CONCLUSION, anxious patients may be harder to anesthetize. However, dentist dedication to preventing pain is the most important behavior to patients.

Oral conscious sedation

Patients in pain are often anxious and fearful of dental treatment.97 Patients reporting for emergency treatment with pain are even more fearful. Therefore, in situations with anxious and fearful patients, will the IANB be more successful if the patient is consciously sedated? Lindemann and coauthors98 determined the effect of the administration of a 0.25-mg sublingual does of triazolam (Halcion, Pfizer) on the efficacy of the IANB in patients experiencing irreversible pulpitis. Success was defined as no or mild pain upon endodontic access or initial instrumentation. The success rate for the IANB was 43% with triazolam and 57% with the placebo. There was no significant difference between the two groups. Likewise, Khademi and coauthors99 found that the preoperative oral administration of 0.5 mg of alprazolam did not improve the success of the IANB in mandibular molars in patients presenting with irreversible pulpitis. Success (no or mild pain upon access or initial instrumentation) was 53% with alprazolam and 40% with the placebo, with no significant difference between the two groups. In conclusion, for mandibular posterior teeth, preoperative triazolam or alprazolam will not result in an increase in success of the IANB in patients with irreversible pulpitis.

Thus, if a painful procedure is anticipated, conscious sedation with triazolam or alprazolam will not reduce pain during dental treatment. Profound local anesthesia is still required. That is, conscious sedation should not be used as a way to reduce pain during dental treatment! The results of these studies should not be interpreted to mean that triazolam or alprazolam sedation should not be used to reduce patients’ anxiety. Anxiety reduction may make the process of dental treatment more acceptable to the patient.

IN CONCLUSION, oral conscious sedation with triazolam (Halcion) or alprazolam (Xanax, Pfizer) will not reduce pain during dental treatment. Profound local anesthesia is still required.

Patient satisfaction with painful treatment

A dentist’s caring manner relates to patient satisfaction even though painful treatment may be involved. A number of studies in endodontics98,100–104 have found high satisfaction ratings (96% to 100%) despite the findings that most patients experienced moderate-to-severe pain during endodontic treatment. Gale and coauthors,105 Davidhizar and Shearer,106 Schouten and coauthors,107 and Fletcher and coauthors108 found that patient satisfaction is related to maintaining a positive and professional attitude, practicing encouragement, exhibiting a caring manner, and avoiding defensiveness. Communicative behavior of the dentist (rapport or “bedside manner”) is positively related to patient satisfaction and explains why patients are satisfied with dental treatment even though pain may be involved. In endodontics, high satisfaction ratings may also be related to the expectation that the patient’s pain will be relieved.

IN CONCLUSION, a dentist’s caring manner relates to patient satisfaction even though painful treatment may be involved. In endodontics, high satisfaction ratings may be related to the expectation that the patient’s pain will be relieved.

Nitrous oxide

Nitrous oxide has an impressive safety record and is excellent for minimal conscious sedation for apprehensive patients.109 Nitrous oxide produces an analgesic effect110–112 and has been used to decrease the pain of venipuncture113 and minor pediatric surgical procedures114 as well as the injection pain of the initial IANB115 using a standard block, Gow-Gates, or Vazirani-Akinosi technique. It has also been used to reduce the pain of IANB injections in children, resulting in improvement in behavior.116

Stanley and coauthors100 determined the effect of nitrous oxide on the anesthetic success of the IANB in patients experiencing symptomatic irreversible pulpitis. They found that nitrous oxide sedation did increase the success of an IANB and was a useful technique in the treatment of painful teeth. Furthermore, if a patient were to present with anxiety and request sedation, nitrous oxide sedation may be preferable to oral sedation. Nitrous oxide sedation allows a titratable dosage, and the patient is not sedated beyond the length of the treatment appointment, meaning the patient would not require someone else to drive after the appointment.

IN CONCLUSION, nitrous oxide is very useful for minimal conscious sedation in apprehensive and emergency patients because it has both analgesic and antianxiety effects.

Aromatherapy

Kiecolt-Glaser and coauthors117 studied aromatherapy and found that it failed to show any improvement in pain control. However, lemon aroma did enhance positive moods, while lavender had no effect on mood. Maybe we should dust with lemon-scented Pledge to enhance the mood of our patients, assistants, and ourselves. Just kidding.

IN CONCLUSION, aromatherapy does not improve pain control in anxious patients.

Vasoconstrictors

Cardiovascular reactions

Several authors118–122 have reported increases in heart rate with infiltration injections and nerve blocks using 2% lidocaine with 1:100,000 epinephrine, while others123–128 have reported no significant changes in heart rate or reported that the changes were clinically insignificant. When specific information was given on dosing and heart rate increases, five studies118–122119,120118,120,121122